Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus

Florine Kastelein; Katharina Biermann; Ewout W Steyerberg; Joanne Verheij; Marit Kalisvaart; Leendert H J Looijenga; Hans A Stoop; Laurens Walter; Ernst J Kuipers; Manon C W Spaander; Marco J Bruno; on behalf of the ProBar-study group

doi:10.1136/gutjnl-2012-303594

Article info

Oesophagus

Original article

Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus

Authors

Florine Kastelein Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands PubMed articles Google scholar articles
Katharina Biermann Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands PubMed articles Google scholar articles
Ewout W Steyerberg Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands PubMed articles Google scholar articles
Joanne Verheij Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands PubMed articles Google scholar articles
Marit Kalisvaart Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands PubMed articles Google scholar articles
Leendert H J Looijenga Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands PubMed articles Google scholar articles
Hans A Stoop Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands PubMed articles Google scholar articles
Laurens Walter Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands PubMed articles Google scholar articles
Ernst J Kuipers Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands Department if Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands PubMed articles Google scholar articles
Manon C W Spaander Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands PubMed articles Google scholar articles
Marco J Bruno Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands PubMed articles Google scholar articles
on behalf of the ProBar-study group
Google scholar articles

Correspondence to Florine Kastelein, Department of Gastroenterology and Hepatology, Erasmus Medical Center, PO Box 2040, Rotterdam 3000 CA, The Netherlands; f.kastelein{at}erasmusmc.nl

View Full Text

Citation

Kastelein F, Biermann K, Steyerberg EW, et al

Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus

Gut 2013;62:1676-1683.

Publication history

Received August 22, 2012
Revised November 29, 2012
Accepted December 1, 2012
First published December 20, 2012.

Online issue publication

March 05, 2018

Article Versions

Previous version (26 October 2017).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password